These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2427402)

  • 1. [Disorders in the release of plasminogen activators].
    Brommer EJ
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(1-2):198-207. PubMed ID: 2427402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Masking of fibrinolytic response to stimulation by an inhibitor of tissue-type plasminogen activator in plasma.
    Brommer EJ; Verheijen JH; Chang GT; Rijken DC
    Thromb Haemost; 1984 Oct; 52(2):154-6. PubMed ID: 6441302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two different mechanisms in patients with venous thrombosis and defective fibrinolysis: low concentration of plasminogen activator or increased concentration of plasminogen activator inhibitor.
    Nilsson IM; Ljungnér H; Tengborn L
    Br Med J (Clin Res Ed); 1985 May; 290(6480):1453-6. PubMed ID: 3922531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunoradiometric determination of blood/tissue plasminogen activators in thrombophilia].
    Astedt B; Fagner U
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(4):475-9. PubMed ID: 6083913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deep vein thrombosis and fibrinolysis. Defective urokinase type plasminogen activator release.
    Levi M; Lensing AW; Büller HR; Prandoni P; Dooijewaard G; Cuppini S; ten Cate JW
    Thromb Haemost; 1991 Oct; 66(4):426-9. PubMed ID: 1796391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the fibrinolytic system in deep vein thrombosis.
    Wiman B; Ljungberg B; Chmielewska J; Urdén G; Blombäck M; Johnsson H
    J Lab Clin Med; 1985 Feb; 105(2):265-70. PubMed ID: 3919125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial-dependent fibrinolysis in subjects with the lupus anticoagulant and thrombosis.
    Francis RB; McGehee WG; Feinstein DI
    Thromb Haemost; 1988 Jun; 59(3):412-4. PubMed ID: 3142079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
    Siegbahn A; Ruusuvaara L
    Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered fibrinolysis in DVT: influence of site of sampling.
    Han P; Koay ES; Tsakok M; Aw TC; Wong LY; Pradhan M
    Thromb Haemost; 1988 Aug; 60(1):50-3. PubMed ID: 3142091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A lysine-absorbable plasminogen activator is elevated in conditions associated with increased fibrinolytic activity.
    Comp PC; Jacocks RM; Rubenstein C; Radcliffe R
    J Lab Clin Med; 1981 May; 97(5):637-45. PubMed ID: 6783711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Poor fibrinolytic response to venous occlusion: defect of endothelial cells or plasma interference?].
    Stalder M; Hauert J; Bachmann F
    Schweiz Med Wochenschr; 1983 Oct; 113(40):1462-4. PubMed ID: 6606226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Dysfunction of fibrinolysis as a risk factor of thrombosis].
    Kołodziejczyk J; Wachowicz B
    Pol Merkur Lekarski; 2009 Oct; 27(160):341-5. PubMed ID: 19928667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A dynamic test to investigate potential tissue plasminogen activator activity. Comparison of deamino-8-D-argininevasopressin with venous occlusion in normal subjects and patients.
    Sultan Y; Harris A; Strauch G; Venot A; De Lauture D
    J Lab Clin Med; 1988 Jun; 111(6):645-53. PubMed ID: 3131470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypofibrinolysis in patients with a history of idiopathic deep vein thrombosis and/or pulmonary embolism.
    Grimaudo V; Bachmann F; Hauert J; Christe MA; Kruithof EK
    Thromb Haemost; 1992 Apr; 67(4):397-401. PubMed ID: 1631786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of fibrinolytic factors in ischaemia.
    Pandolfi M; al-Rushood A
    Eye (Lond); 1991; 5 ( Pt 2)():159-69. PubMed ID: 2070877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deficient t-PA release and elevated PA inhibitor levels in patients with spontaneous or recurrent deep venous thrombosis.
    Juhan-Vague I; Valadier J; Alessi MC; Aillaud MF; Ansaldi J; Philip-Joet C; Holvoet P; Serradimigni A; Collen D
    Thromb Haemost; 1987 Feb; 57(1):67-72. PubMed ID: 3109059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A family with reduced plasminogen activator activity in blood associated with recurrent venous thrombosis.
    Jørgensen M; Mortensen JZ; Madsen AG; Thorsen S; Jacobsen B
    Scand J Haematol; 1982 Sep; 29(3):217-23. PubMed ID: 6890710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postoperative changes in the plasmatic levels of tissue-type plasminogen activator and its fast-acting inhibitor--relationship to deep vein thrombosis and influence of prophylaxis.
    Páramo JA; Alfaro MJ; Rocha E
    Thromb Haemost; 1985 Oct; 54(3):713-6. PubMed ID: 3937269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of temperature on the release of plasminogen activator.
    Fracasso JF; Rodrigues LA; Yashuda Y
    Braz J Med Biol Res; 1988; 21(1):31-3. PubMed ID: 3179575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrinolysis during normal pregnancy and severe preeclampsia relationships between plasma levels of plasminogen activators and inhibitors.
    Nakashima A; Kobayashi T; Terao T
    Gynecol Obstet Invest; 1996; 42(2):95-101. PubMed ID: 8878712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.